Drug Profile
TRK 700
Alternative Names: TRK700Latest Information Update: 28 Nov 2022
Price :
$50
*
At a glance
- Originator Toray Industries
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Peripheral nervous system diseases; Postherpetic neuralgia
Most Recent Events
- 28 Nov 2022 No recent reports of development identified for preclinical development in Peripheral-nervous-system-diseases(Chemotherapy-induced) in Japan (PO)
- 16 Feb 2022 No development reported - Phase-II for Postherpetic neuralgia (In the elderly, In adults) in Japan (PO)
- 12 Sep 2018 Pharmacodynamics data from a preclinical trial in Peripheral neuropathy presented at the 17th World Congress on Pain (WCP-2018)